Akesis, Inc. Information

Akesis, named after the Greek god of healing, is a U.S.-based radiation oncology technology company dedicated to making precise, effective cancer treatment accessible to more patients worldwide. We bring innovative radiation therapy systems to the global market, combining advanced rotational technology, real-time in-line imaging, and adaptive therapy capabilities. Our products are assembled and supported in the United States, with a commitment to quality, regulatory rigor, and responsive service. Our Products The Gemini360RT™ is a ring-gantry-based linear accelerator system with FDA 510(k) clearance, engineered for a broad range of treatments including IG-IMRT, VMAT, SBRT, SRS/FRS, 3DCRT, and palliative treatments. It supports both online and offline adaptive radiation therapy, enabling clinicians to modify treatment plans intelligently over the course of therapy. The first U.S. patient treatment was successfully delivered at Advanced Radiation Centers of New York in December 2025. The Galaxy RTi® is our FDA-cleared rotational gamma radiosurgery system, designed to deliver precise stereotactic radiosurgery with patented continuous rotational technology and real-time in-line imaging. Our Mission Radiation medicine remains underutilized and inaccessible in many parts of the world. At Akesis, we are committed to closing that gap. We deliver simple, safe, and reliable treatment technologies that empower clinicians and transform patient outcomes. 📍 Concord, CA | 🌐 akesis.com | 📞 +1 925.202.0321